gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · SYKHealthcareSurgical Instruments

Stryker Corporation (SYK)

$339.65+9.37%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$339.65▼ 6.33% in range
Nov 4, 2025Low $269.75 · High $387.46Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Stryker closed at $339.65 on Nov 4, up 9.37%, 12.3% below its 52-week closing high. Volume of 6.5M shares was 2.37× its 20-day average (well above normal).

Split-adjusted performance: +22.1% over one month, +16.2% over six months, -5.2% over one year.

In the quarter ended Sep 30, 2026, revenue was $6.52B, up 7.6% from a year earlier, with a net margin of 11.5%.

Short interest was 5.7M shares at the Oct 15 settlement (1.6% of float, 2.4 days to cover).

Market cap$130.28B383.6M shares
Revenue · quarter$6.52B+7.6% YoY
Diluted EPS$1.96−11.7% YoY
P/E · TTM36.0×P/S 5.0×
Net margin11.5%Gross 65.2%
Dividend yield1.04%$0.88 last paid
52-week range269.75 – 387.46−12.3% from high
Volume6.5M2.37× 20-day avg
Volatility · 60d40.6%Annualised
Short % of float1.6%2.4 days to cover
Net cash-$11.66BCash $3.27B
Next earnings—Not scheduled
Split-adjusted performance
1W +11.7%1M +22.1%3M +0.7%6M +16.2%YTD −3.4%1Y −5.2%3Y +29.4%5Y +26.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum66
Revenue growth47
Net margin83
Value (low P/E)30
Size100

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short5.7M−0.7% vs prior
Days to cover2.4Settled Oct 15
% of float1.6%
Short vol. 10d55.0%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
SYKStryker$339.65+9.37%+16.2%+7.6%11.5%36.0$130.28B
MMM3M$193.95+9.55%+32.4%+1.0%20.9%28.3$100.02BCompare
BSXBoston Scientific$45.82+5.33%−18.2%+1.4%11.3%19.0$66.40BCompare
BDXBecton, Dickinson and$209.19+5.56%+44.5%+5.4%7.6%60.6$56.98BCompare
MDLNMedline$40.35+18.36%−4.0%—0.8%—$35.40BCompare
RMDResMed$240.51+5.91%+14.7%+5.9%29.6%21.2$33.83BCompare
DXCMDexCom$88.48+6.64%+46.6%+11.2%20.5%33.3$33.00BCompare
WSTWest Pharmaceutical Services$408.78+0.44%+30.8%+8.7%24.5%44.6$28.48BCompare
SOLVSolventum$89.35+5.42%+25.9%+2.2%4.2%10.6$15.21BCompare

News about Stryker

All news →
Are Options Traders Betting on a Big Move in Stryker Stock?Zacks Investment Research · 16h ago▼ NegativeSYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutZacks Investment Research · 5d ago▼ NegativeSYK Q3 Earnings Call Highlights Softer Demand and Revised OutlookZacks Investment Research · 5d ago▼ NegativeStryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research · 6d ago▼ NegativeStryker (SYK) Q3 Earnings and Revenues Lag EstimatesZacks Investment Research · 6d ago▼ Negative

Quick answers

What does Stryker do?
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics.
What is SYK's market cap?
$130.28B, based on the Nov 4 close of $339.65.
What is SYK's P/E ratio?
36.0× trailing-twelve-month earnings of $3.62B.
Does Stryker pay a dividend?
Yes. The latest regular dividend was $0.88 per share (ex-date Sep 30), an annualised yield of 1.04%.
How much of SYK is sold short?
5.7M shares, 1.6% of float, as of Oct 15, 2026.
What sector is SYK in?
Healthcare, in the Surgical Instruments industry.

About Stryker

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

HQ: Portage, MI56,000 employeesListed May 2, 1979stryker.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology